Grass Pollen Allergy – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Grass Pollen Allergy – Drugs In Development, 2024 report and make more profitable business decisions.
Grass pollen allergy is a reaction which occurs soon after exposure to pollen from grasses. Signs and symptoms include skin reactions such as hives, redness, or swelling; itching or tingling in or around the mouth and throat; tightening of the throat; shortness of breath or wheezing; and runny nose. Predisposing factors include age, family history, and other allergies.
The Grass Pollen Allergy drugs in development market research report provide comprehensive information on the therapeutics under development for Grass Pollen Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Grass Pollen Allergy and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Grass Pollen Allergy | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 11 molecules, with 11 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Grass Pollen Allergy therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Grass Pollen Allergy pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Grass Pollen Allergy treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Allergy Therapeutics PlcDC4U BV
H. Lundbeck AS
HAL Allergy BV
Mabylon AG
Regeneron Pharmaceuticals Inc
Revolo Biotherapeutics Ltd
Roxall Medizin GmbH
Worg Pharmaceuticals Hangzhou Co Ltd
Zonhon Biopharma Institute Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Grass Pollen Allergy reports